Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study

被引:9
作者
Chidambaram, Swathikan [1 ]
Owen, Richard [2 ,3 ]
Sgromo, Bruno [2 ]
Chmura, Magdalena [2 ]
Kisiel, Aaron [4 ]
Evans, Richard [4 ]
Griffiths, Ewen A. [4 ]
Castoro, Carlo [5 ]
Gronnier, Caroline [6 ]
Maoawyes, Mometo Ali [7 ]
Gutschow, Christian A. [7 ]
Piessen, Guillaume [8 ]
Degisors, Sebastien [8 ]
Alvieri, Rita [9 ]
Feldman, Hope [10 ]
Capovilla, Giovanni [11 ]
Grimminger, Peter P. [11 ]
Han, Shiwei [12 ,13 ]
Low, Donald E. [12 ,13 ]
Moore, Jonathan [14 ]
Gossage, James [14 ]
Voeten, Dan [15 ]
Gisbertz, Suzanne S. [15 ]
Ruurda, Jelle [16 ]
van Hillegersberg, Richard [16 ]
D'Journo, Xavier B. [17 ]
Chmelo, Jakub [18 ]
Phillips, Alexander W. [18 ]
Rosati, Riccardo [19 ]
Hanna, George B. [1 ]
Maynard, Nick [2 ]
Hofstetter, Wayne [10 ]
Ferri, Lorenzo [20 ]
Berge Henegouwen, Mark I. [15 ]
Markar, Sheraz R. [2 ,21 ]
机构
[1] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit, London, England
[2] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Surg, Oxford, England
[3] Univ Oxford, Ludwig Inst Canc Res, Oxford, England
[4] Birmingham Univ Hosp NHS Fdn Trust, Queen Elizabeth Hosp, Dept Surg, Birmingham, England
[5] Humanitas Res Hosp, Gen Gastr & Esophagus Surg Unit, Rozzano, Italy
[6] CHU Bordeaux, Ctr Magellan, Digest Surg Dept, Esophageal & Endocrine Surg Unit, Bordeaux, France
[7] Univ Hosp Zurich, Comprehens Canc Ctr, Stomach & Oesophageal Tumor Ctr, Zurich, Switzerland
[8] Univ Hosp Claude Huriez, Dept Digest & Gen Surg, Cedex, Lille, France
[9] IOV IRCCS, Veneto Inst Oncol, Oncol Surg Unit, Padua, Italy
[10] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Surg, Mainz, Germany
[12] Virginia Mason Hosp, Dept Thorac Surg & Thorac Oncol, Seattle, WA USA
[13] Seattle Med Ctr, Seattle, WA USA
[14] Guys & St Thomas Hosp NHS Fdn Trust, Dept Surg, London, England
[15] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[16] Univ Med Ctr, Dept Upper Gastrointestinal Surg, Utrecht, Netherlands
[17] North Hosp, Dept Thorac Surg Dis Esophagus & Lung Transplantat, Chemin Bourrely, Marseille, France
[18] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Esophagogastr Unit, Newcastle Upon Tyne, England
[19] Osped San Raffaele, Dept GI Surg, Milan, Italy
[20] McGill Univ, Montreal Gen Hosp, Dept Surg & Oncol, Montreal, PQ, Canada
[21] Univ Oxford, Nuffield Dept Surg, Oxford, England
关键词
chemoradiotherapy; esophageal cancer; esophagectomy; salvage esophagectomy; PHASE-III TRIAL; RADIATION-THERAPY; SURGERY; CHEMORADIATION; RADIOTHERAPY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES;
D O I
10.1097/SLA.0000000000006028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer.Background: CRT is a core component of multimodality treatment for locally advanced esophageal cancer. The timing of surgery following CRT may influence the probability of performing an oncological resection and the associated operative morbidity.Methods: This was an international, multicenter, cohort study, including patients from 17 centers who received CRT followed by surgery between 2010 and 2020. In the main analysis, patients were divided into 4 groups based upon the interval between CRT and surgery (0-50, 51-100, 101-200, and >200 days) to assess the impact upon 90-day mortality and 5-year overall survival. Multivariable logistic and Cox regression provided hazard ratios (HRs) with 95% CIs adjusted for relevant patient, oncological, and pathologic confounding factors.Results: A total of 2867 patients who underwent esophagectomy after CRT were included. After adjustment for relevant confounders, prolonged interval following CRT was associated with an increased 90-day mortality compared with 0 to 50 days (reference): 51 to 100 days (HR=1.54, 95% CI: 1.04-2.29), 101 to 200 days (HR=2.14, 95% CI: 1.37-3.35), and >200 days (HR=3.06, 95% CI: 1.64-5.69). Similarly, a poorer 5-year overall survival was also observed with prolonged interval following CRT compared with 0 to 50 days (reference): 101 to 200 days (HR=1.41, 95% CI: 1.17-1.70), and >200 days (HR=1.64, 95% CI: 1.24-2.17).Conclusions: Prolonged interval following CRT before esophagectomy is associated with increased 90-day mortality and poorer long-term survival. Further investigation is needed to understand the mechanism that underpins these adverse outcomes observed with a prolonged interval to surgery.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [41] Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature
    Hategan, M.
    Cook, N.
    Prewett, S.
    Hindmarsh, A.
    Qian, W.
    Gilligan, D.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (07) : 612 - 618
  • [42] Salvage lymphadenectomy without esophagectomy is an option for recurrent or residual lymph nodes after definitive chemoradiotherapy for esophageal cancer
    Matono, Satoru
    Fujita, Hiromasa
    Tanaka, Toshiaki
    Mori, Naoki
    Nagano, Takeshi
    Nishimura, Kohei
    Hino, Haruhiro
    Shirouzu, Kazuo
    Eto, Hidehiro
    Ogo, Etsuyo
    Yanagawa, Takashi
    ESOPHAGUS, 2014, 11 (03) : 197 - 203
  • [43] DOSE VOLUME HISTOGRAM PARAMETERS AND CLINICAL FACTORS ASSOCIATED WITH PLEURAL EFFUSION AFTER CHEMORADIOTHERAPY IN ESOPHAGEAL CANCER PATIENTS
    Shirai, Katsuyuki
    Tamaki, Yoshio
    Kitamoto, Yoshizumi
    Murata, Kazutoshi
    Satoh, Yumi
    Higuchi, Keiko
    Nonaka, Tetsuo
    Ishikawa, Hitoshi
    Katoh, Hiroyuki
    Takahashi, Takeo
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1002 - 1007
  • [44] Scoring System for Predicting Recurrence after Chemoradiotherapy Including 5-Fluorouracil and Platinum for Patients with Esophageal Cancer
    Kogo, Mari
    Suzuki, Ayako
    Sunaga, Tomiko
    Kaneko, Kazuhiro
    Yoneyama, Keiichiro
    Imawari, Michio
    Kiuchi, Yuji
    HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 1979 - 1984
  • [45] Surgical Therapy an Chemoradiotherapy for Postoperative Recurrent Esophageal Cancer
    Kubota, Keisuke
    Kuroda, Junko
    Yoshida, Masashi
    Ohta, Keiichiro
    Suwa, Tatsushi
    Mafune, Ken-ichi
    Kawase, Takatsugu
    Kitahara, Tadashi
    Kubo, Atsushi
    Kitajima, Masaki
    HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 1961 - 1965
  • [46] Proximal esophageal cancer-a case for chemoradiotherapy
    Nicolay, Nils Henrik
    ONKOLOGE, 2020, 26 (04): : 317 - 322
  • [47] Anastomotic leak and neoadjuvant chemoradiotherapy in esophageal cancer
    Shridhar, Ravi
    Takahashi, Caitlin
    Huston, Jamie
    Doepker, Matthew P.
    Meredith, Kenneth L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (05) : 894 - 902
  • [48] Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy
    Favareto, Sergio L.
    Sousa, Cecilia F.
    Pinto, Pedro J.
    Ramos, Henderson
    Chen, Michael J.
    Castro, Douglas G.
    Silva, Maria L.
    Gondim, Guilherme
    Pellizzon, Antonio Cassio A.
    Fogaroli, Ricardo C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [49] Delayed Surgical Resection After Long-course Neoadjuvant Chemoradiotherapy in Rectal Cancer: Single Center Experience
    Mermut, Ozlem
    Inanc, Berrin
    Arslan, Esra
    Bektas, Hasan
    Dursun, Nevra
    Yardimci, Aytul Hande
    ISTANBUL MEDICAL JOURNAL, 2019, 20 (05): : 424 - 430
  • [50] Survival After Surgical Resection of Stage IV Esophageal Cancer
    Saddoughi, Sahar A.
    Reinersman, J. Matthew
    Zhukov, Yuriy O.
    Taswell, James
    Mara, Kristin
    Harmsen, S. William
    Blackmon, Shanda H.
    Cassivi, Stephen D.
    Nichols, Francis, III
    Shen, K. Robert
    Wigle, Dennis A.
    Allen, Mark S.
    ANNALS OF THORACIC SURGERY, 2017, 103 (01) : 261 - 266